Efficacy and safety of 28-day treatment with oral insulin (ORMD-0801) in patients with type 2 diabetes: A randomized, placebo-controlled trial.

Roy EldorJoel NeutelKenneth Homer Miriam Kidron

Published in: Diabetes, obesity & metabolism (2021)

In patients with T2D, bedtime ORMD-0801 curbed increases in night-time glycaemia, 24-hour glycaemia and HbA1c, without increasing the risk of hypoglycaemia or safety events compared with the control arm.

Keyphrases

type diabetes
blood pressure
double blind
randomized controlled trial
study protocol
glycemic control
adipose tissue
combination therapy
physical activity
depressive symptoms
replacement therapy
smoking cessation